RSS

CVM Cel-Sci Corp.

Mod: mick
Last Post: 11/06/23
Followers: 1
Posts Today: 0
Views Today: 33

CVM Stock Quote & Tools

$2.0900 ▲ +0.0300 (+1.46%) As of Oct 1, 4:00 PM EDT
Last2.0900
$ Chg0.0300
Open2.0600
High2.3000
Beta0.5886
Year High10.830
Market Cap36.76M
P/B Ratio3.31
EPS-1.03
Avg Vol (30d)154.0K
Volume810.3K
% Chg+1.46%
Prev Close2.0600
Low1.9563
VWAP2.16580
Year Low0.890
Total Shares17.59M
Shares Out17.59M
Float16.77M
ExchangeNYSE American
Healthcare Biotechnology & Life Sciences

CVM Stock Message Board Discussion

  1. mick

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Qifu Technology Transitions to Qfin Holdings and New Strategies

Updated Category News Views 308

Leadership Changes at Qifu Technology Recently, Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) held its annual general meeting where shareholders adopted key resolutions that will shape the company’s future. One of the notable changes is the rebranding of the company from Qifu Technology, Inc. to Qfin Holdings, Inc. This transition reflects the ambitious growth...

Continue Reading
Luokung's Journey to Nasdaq Compliance and Future Prospects

Updated Category News Views 47

Luokung Completes Compliance with Nasdaq Regulations Luokung Technology Corp. (NASDAQ: LKCO) has exciting news regarding its compliance status with Nasdaq. Recently, the Nasdaq Stock Market notified the company that it has successfully met the minimum bid price requirement. This is a significant development for Luokung, highlighting its positive performance in the stock...

Continue Reading
Qubrid AI Forms Alliance with ASI for Advanced AI Solutions

Updated Category News Views 157

Qubrid AI Partners with ASI for Enhanced Distribution Qubrid AI, a pioneer in enterprise AI technologies, has recently established a distribution agreement with ASI Corporation, a respected technology distributor. This collaboration aims to enhance market access for Qubrid AI's state-of-the-art AI Controller software and high-performance GPU Appliances. Expanding Access...

Continue Reading
Bexion Pharmaceuticals Secures Grant to Propel BXQ-350 Research

Updated Category News Views 198

Bexion Pharmaceuticals Receives Michael J. Fox Foundation Grant Bexion Pharmaceuticals, Inc., a dedicated clinical-stage biopharmaceutical company, has received a substantial grant to support its innovative research initiatives. This grant, awarded by The Michael J. Fox Foundation for Parkinson's Research, amounts to $1.4 million and will specifically fund the preclinical...

Continue Reading
Class Action Alert: Investors of James Hardie Should Act Soon

Updated Category News Views 98

Class Action Alert for James Hardie Industries PLC Investors Attention to all investors of James Hardie Industries PLC (NYSE: JHX)! If you're among those who purchased James Hardie common stock or American Depositary Shares, this is a critical time for you. Recent developments have unveiled a class action lawsuit that demands immediate attention. This action is initiated...

Continue Reading